Methods and reagents for inhibiting angiogenesis
US6420345B1 · kind B1 · utility
8Cited by
5References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 9, 1999 |
| Grant date | Jul 16, 2002 |
| Priority date | — |
| Expiry date | Dec 9, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for inhibiting angiogenesis using cyclin dependent kinase inhibitors (CDKi) and fusion proteins thereof, recombinant viruses comprising transgenes and nucleic acid sequences encoding the same, and liposomes carrying the same as angiogenesis-inhibiting reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.